Covered recipient · General Payments record
CARLY NICOLE RAY
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2025
$376.64
- Reported across 17 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): (records>=3 OR total>=100) AND records>=2 AND NPI identity (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $376.64 | 17 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $235.63 | 9 |
| PFIZER INC. | $77.63 | 4 |
| Teva Pharmaceuticals USA, Inc. | $31.96 | 2 |
| SK Life Science, Inc. | $16.56 | 1 |
| TONIX PHARMACEUTICALS, INC. | $14.86 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2025 | $376.64 | 17 |
Payment records · PY2025 (17)
Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $102.52 | 08/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203792246 | CMS |
| ABBVIE INC. | $9.55 | 10/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203792251 | CMS |
| ABBVIE INC. | $17.18 | 10/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203792257 | CMS |
| ABBVIE INC. | $13.01 | 11/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203792264 | CMS |
| ABBVIE INC. | $14.54 | 11/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203792270 | CMS |
| ABBVIE INC. | $21.18 | 11/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203792276 | CMS |
| ABBVIE INC. | $16.39 | 12/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203792281 | CMS |
| ABBVIE INC. | $17.86 | 12/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203792288 | CMS |
| ABBVIE INC. | $23.40 | 12/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203792294 | CMS |
| PFIZER INC. | $17.47 | 10/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1230618631 | CMS |
| PFIZER INC. | $22.47 | 10/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1230614984 | CMS |
| PFIZER INC. | $16.99 | 12/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1231001157 | CMS |
| PFIZER INC. | $20.70 | 12/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1231148193 | CMS |
| SK Life Science, Inc. | $16.56 | 10/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1252287943 | CMS |
| Teva Pharmaceuticals USA, Inc. | $14.46 | 11/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1247464077 | CMS |
| Teva Pharmaceuticals USA, Inc. | $17.50 | 12/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1247464135 | CMS |
| Tonix Medicines, Inc. | $14.86 | 11/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235873648 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2025
- Source files
- Dataset page · Bulk file · PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.